Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118726 · ClinicalTrials.gov registry record
Evaluation of Immediate Postpartum LARC Implementation Programs
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 21
- Enrollment target
NCT03118726: Completed study, sponsored by University of New Mexico.
NCT03118726 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03118726 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study will engage hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs. All hospitals in New Mexico interested in implementing immediate postpartum LARC programs will be eligible to participate in the NPMC program evaluation. The study will evaluate the components of this implementation program at several New Mexico hospitals using a stepped wedge design,with components being introduced to each hospital one at a time
Primary Outcome
To determine baseline immediate postpartum LARC implementation in various rural New Mexico hospitals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-04-13 |
| Est. Completion | 2019-05-31 |
What the finished NCT03118726 record still lists
NCT03118726 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03118726 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03118726 about?
NCT03118726 is a clinical study titled "Evaluation of Immediate Postpartum LARC Implementation Programs". This study will engage hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs. All hospitals in New Mexico interested in implementing immediate postpartum LARC programs will be eligible to participate in...
What is the current status of trial NCT03118726?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2017-04-13. Estimated completion is 2019-05-31.
Who is sponsoring clinical trial NCT03118726?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI